Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Possible Role of Angiotensin Peptide (1-7) on Treatment of COVID-19

NCT04375124 is registered in ClinicalTrials.gov with Kanuni Sultan Suleyman Training and Research Hospital as lead sponsor.

NCT NCT04375124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04375124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Possible Role of Angiotensin Peptide (1-7) on Treatment of COVID-19
Lead sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 25, 2020
Completion date
September 30, 2020
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19